Serologic Profile of SARS CoV2 in COVID-19 Patients With Systemic Diseases
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Behçet Disease
- Inflammatory Myopathy
- Rheumatoid Arthritis
- Sarcoidosis
- SARS-CoV Infection
- Sjogren's Syndrome
- Spondyloarthritis
- Systemic Disease
- Systemic Lupus Erythematosus
- Type
- Observational
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
The study is a prospective, observational, multicenter clinical trial to be conducted in the internal medicine, rheumatology and virology departments of Military Hospital of Tunis. After obtaining informed consent from the patient, the investigator will perform an inclusion visit made of a patient i...
The study is a prospective, observational, multicenter clinical trial to be conducted in the internal medicine, rheumatology and virology departments of Military Hospital of Tunis. After obtaining informed consent from the patient, the investigator will perform an inclusion visit made of a patient interview and performing blood sample to search for IgG and anti-SARS IgM CoV2. Patients with IgM-like antibodies will have an RT-PCR test for active infection. If the study participants will be diagnosed with COVID-19 positive during the study period, the attending physician is entitled to decide on their management based on the severity of the clinical status.
Tracking Information
- NCT #
- NCT04530461
- Collaborators
- UR17DN02 : Autoimmune Diseases Research Unit
- Investigators
- Study Chair: Faida Ajili, MD Military Hospital of Tunis
Get Well Soon